Novo Nordisk A/S (NYSE:NVO) Given Price Target Of $60.1


As per Novo Nordisk A/S (NYSE:NVO)’s news release on 2016-03-24, its shareholders will get cash dividend of $0.69944 per share. The recent press release updated on the record date and payout date, which stands at 2016-03-22 and 2016-03-30, respectively.

The stock of Novo Nordisk A/S (NYSE:NVO) will commence trading ex-dividend from 2016-03-18, until which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Novo Nordisk A/S (NYSE:NVO) disbursed $0.699 in dividend compared to distribution of $0.606, a year ago. It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of -12.0834%.

The past track record of five years substantiates that the average payout of Novo Nordisk A/S (NYSE:NVO) stands at $0.446, implying 22.1794% growth. The company recorded earnings of $0.48 a share in the preceding fiscal.

The interim price target for Novo Nordisk A/S (NYSE:NVO) is set at $60.1. This level is the mean price reached by averaging the stock views of 1 analysts. All these are top brokerages of Wall Street and trail the company’s performance regularly. The best price estimate is seen at $60.1 and the lowest level is established at 60.1. This broad range highlights a standard deviation of $0 in reported estimates.

AlphaOne has allotted A sentiment score of 0.115 to Novo Nordisk A/S (NYSE:NVO) while impact score assigned is 0 as on as on 2016-07-09.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)